...María Isabel Peña-Cano; Renata Saucedo; Enrique Morales-Avila; Jorge Valencia; Jose A. Zavala-Moha; Adriana López Background: Obesity is a risk factor for breast cancer (BC). Some mechanisms through which obesity can lead to cancer development are insulin-like growth factors (IGFs), adipokines...

...Rong Wang; Jinbin Li; Chunyu Yin; Di Zhao; Yulan Zhao; Yapeng Li; Ling Yin Background: This study aimed to investigate the action mechanism of β-estradiol in MCF-7 breast cancer (BC) cells. Methods: The cell samples were sequenced using Hiseq 2000, including 2 MCF-7 controls and 2 samples treated...

...Katharina Redling; Fabienne Schwab; Matthias Siebert; Andy Schötzau; Rosanna Zanetti-Dällenbach Background: The study aimed to improve breast cancer diagnosis with new ultrasound (US) modalities. We examined whether real-time elastography (RTE) complements the diagnostic performance of US. Methods...

...-Fierro; Luis de-Leon-Zaragoza; Bertha A. Olmedo-Buenrostro; Ivan Delgado-Enciso Background/Aims: Breast cancer is the most common gynecologic malignancy known worldwide. The consumption of certain foods may modify the risk for its development. Peanuts and other seeds have shown anticarcinogenic effects...

...Mariana Panal; José I. Sánchez-Mendez; Rocio Revello; Daniel Abehsera; Javier de Santiago; Ignacio Zapardiel Aims: Breast cancer is the most frequently diagnosed cancer among women. Up to 50% of breast cancer cases occur in patients over the age of 65 years. Hormonal therapy as a single alternative...

...Masataka Sawaki; Ai Idota; Hiroki Uchida; Sumiyo Noda; Shigenori Sato; Toyone Kikumori; Tsuneo Imai Background: Tamoxifen (TAM) and toremifene (TOR) prevent estrogen from stimulating breast cancer growth and also have agonistic effects in a number of physiological systems. TAM is known to increase...

... by cyclophosphamide. JAMA 1964;188:423–426. 6. Di Fonzo LA, O’Connell TX: Breast cancer in pregnancy and lactation. Surg Clin North Am 1996;76:267–279. 7. Mir O, Berveiller P, et al: Chemotherapy for breast cancer during pregnancy: is epirubicine safe? Ann Oncol 2008;19:1814–1815. 8. Enns GM, Roeder E...

... Nafoxidine U 11 100 A Antiestrogens Prolactin Breast Cancer Hormones and Antagonists. Gynec. Invest. 2: 130-137 (1971/72) Inhibition of DMBA-Induced Mammary Carcinogenesis in the Rat by 2-Br-a-Ergocryptine (CB 154), An Inhibitor of Prolactin Secretion, and by Nafoxidine (U -ll, 100 A), an Estrogen...

... indication of a relation between cytosol and nuclear binding, the relation between steroid structure and specific uterine binding in vitro and the prediction of response of human breast cancers to adrenalectomy orhypophysectomy. Hormones and Antagonists. Gynec. Invest. J: 108-123 (1972) The Use of Estrogen...

...Antonio Cano; José; Rivera; Juan José; Parrilia; Lorenzo Abad The concentration of P29, a phosphoprotein related to estradiol receptor (RE), was measured by an immunoradiometric assay in human breast cancer cytosol and the results compared with the levels of RE and progesterone receptors (RP...

... and GCDFP-15 markers have been useful in detecting breast cancer. The application of radionuclide imaging will provide a new field for the diagnosis of gynecologic malignancies. 27 11 1991 12 12 1991 2 3 2010 © 1992 S. Karger AG, Basel 1992 Copyright / Drug Dosage / Disclaimer...

...Susumu Terada; Kiyoshi Uchide; Nobutaka Suzuki; Kazutomo Akasofu A large ovarian follicular cyst developed on day 43 of low-dose tamoxifen adjuvant therapy for a premenopausal breast cancer (total drug intake: 860 mg). The serum estradiol level increased to almost ten times the pretreatment level...

... (51%) underwent PS. They were more likely to be a BRCA2 mutation carrier, parous, married, employed, and had a prior history of breast cancer. PS included 39 bilateral salpingo-oophorectomies and 13 mastectomies. Pathology was typically benign; however, 15% showed ductal carcinoma in situ...

...). This difference did not reach significance in patients with breast cancer (328 ± 169 IU/l; p = 0.17)). Uterine leiomyoma patients showed intermediate LDH levels (310 ± 81 IU/l), while patients with breast fibroadenomas and ovarian cystadenomas had LDH serum levels close to carcinomas (308 ± 60 and 348 ± 135 IU/l...

...Benedito Borges da Silva; Cleicilene Gomes Pires; Alesse Ribeiro dos Santos; Adriel Herbert de Castro-Leão; Airlane Pereira Alencar; Pedro Vitor Lopes-Costa Background: The aim of this study was to evaluate the effect of raloxifene on CD34 and Ki-67 antigen expression in breast cancer specimens...

..., endometrial polyps, and endometrial hyperplasia. Case Report: A 54-year-old perimenopausal woman on tamoxifen (20 mg/day), gravida 0, with surgically treated invasive lobular breast cancer and extensive lobular carcinoma in situ (pT2 (m) pN0 (snl) pL0 G2 pTis (LCLIS) R0 M0 Ki-67 1%, ER+, PR+, Her-2-neu...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Spontaneous remission Breast cancer Apoptosis Cancer behavior Case Report Gynecol Obstet Invest 2008;65:206 211 DOI: 10.1159/000112228...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Breast cancer Hormone replacement therapy Tibolone Estrogens Progestin Sulfatase Sulfotransferase Proliferation...

...Kim E. Innes; Lindsay Weitzel; Mark Laudenslager Preeclampsia has been linked to increased risk for cardiovascular disease and, more recently, to reduced risk for breast cancer later in life. The altered chronic disease risk associated with prior preeclampsia may reflect underlying metabolic...

.... Breast cancer Endocrine factors, breast cancer Obesity Hormone receptors Original Paper Gynecol Obstet Invest 2001;52:264 268 Received: September 24, 1999 Accepted after revision: June 29, 2001 Hormone-Related Factors Associated with Hormone Receptor Levels in Breast Cancer Leobardo Calzada José...